Synthesis and activity of dermorphin-growth hormone releasing factor hybrid peptides

Marastoni, M.; Salvadori, S.; Balboni, G.; Borea, P.A.; Tomatis, R.

Arzneimittel-Forschung 39(6): 639-641

1989


ISSN/ISBN: 0004-4172
PMID: 2505781
Document Number: 338234
Dermorphin- growth hormone releasing factor (GRF) hybrid peptides (Y-Tyr-D-Ala-Xaa-Gly-Tyr-Pro-Ser-NH2) were synthesized and tested for opioid activity and their ability to stimulate growth hormone (GH) secretion. The substitution of Phe3 for Asp and Glu in dermorphin or its N-terminal acetylation produced peptides with no affinity for opioid receptors but significant, even if low, GRF-like activity.

Document emailed within 1 workday
Secure & encrypted payments